Neuroone Medical Technologies (NMTC) Current Leases (2023 - 2024)
Neuroone Medical Technologies' (NMTC) quarterly Current Leases came in at $65768.0 in Q3 2024, down 49.06% on a YoY basis from $129116.0 in Q4 2023, and down 49.06% quarter-over-quarter from $129116.0 in Q3 2023.
Powered by 
Analysis
Neuroone Medical Technologies (NMTC) Current Leases (2023 - 2024) Analysis & Trends
Neuroone Medical Technologies (NMTC) has reported Current Leases for 2 consecutive years, with $65768.0 the latest figure, recorded in Q3 2024.
- For the quarter ending Q3 2024, Current Leases fell 49.06% year-over-year to $65768.0; the trailing twelve-month figure through Sep 2024 stood at $65768.0 (down 49.06% YoY), and the FY2024 full-year result was $65768.0, down 49.06% from the prior year.
- Current Leases retreated to $65768.0 in Q3 2024 per NMTC's latest filing, from $129116.0 in the prior quarter.
- Across five years, Current Leases topped out at $129116.0 in Q3 2023 and bottomed at $65768.0 in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 24.10 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 81.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 20.70 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 35.60 Mn |
| 10 | Neuroone Medical Technologies | 14.33 Mn | 12.29 Mn | 1.18 Mn | - |